Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
5
×
national top stories
biotech
clinical trials
national
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston
boulder/denver blog main
boulder/denver top stories
cancer
depression
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
third rock ventures
wisconsin blog main
wisconsin top stories
ally bridge group
antidepressant
antisense oligonucleotide
assurex health
benzodiazepines
big data analytics
biogen
blackrock
What
genetic
5
×
new
5
×
cancer
medicine
drug
medicines
aims
analysis
approved
backed
bio
biotech
bring
cas
cause
cells
centers
ceo
company
crispr
cut
deeper
defect
depression
develop
diseases
dna
drive
drugs
edited
editing
employing
epilepsy
event
fda
fears
fingerprint
flag
gene
genes
Language
unset
Current search:
new
×
" national blog main "
×
genetic
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?